NCT02500667View on ClinicalTrials.gov

A Drug-Drug Interaction Study of N91115 +/- Rifampin in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Drug Interaction Potentiation
Interventions
DRUG

N91115

200 mg BID

DRUG

Rifampin

600 mg QD

Trial Locations (1)

80228

St. Anthony's Medical Plaza 1, Lakewood

Sponsors

Collaborators (1)

Davita Clinical Research
All Listed Sponsors
collaborator

Davita Clinical Research

INDUSTRY

lead

Nivalis Therapeutics, Inc.

INDUSTRY